Skip to content
Home/Companies/Biotech/Pheno Therapeutics
PT

Pheno Therapeutics

Biotech·UK·Active·6yr hold

Pheno Therapeutics is a biotech company, headquartered in UK.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns Pheno Therapeutics?

Pheno Therapeutics is currently owned by LifeArc through LifeArc Ventures (1992 vintage), since 2020.

Hand-verified · updated 2026-05-31

LifeArc
Investor
LifeArc
LifeArc Ventures · 1992 · Life Sciences VC

Key facts

HQUK
SectorBiotech
StatusActive

More from LifeArc Ventures

Other portfolio companies in the same fund.

Fluid Biomed
Active
MedTechCanada· 2024
Affect Therapeutics
Active
HealthTechUnited States· 2023
Cytospire Therapeutics
Active
BiotechUK· 2023
Maxion Therapeutics
Active
BiotechUK· 2023
Ozlo Sleep
Active
HealthTechUnited States· 2023
RQ Biotechnology
Active
BiotechUK· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings